Delivery Order SPE2DR25D6028-SPE2DR26FARJP
- Not listed
- The Defense Logistics Agency awarded a $20,986.24 delivery order contract to AmerisourceBergen Drug Corp for Act-O-Vials on October 29, 2025, with completion expected by October 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,465.42 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company will perform the work from its Corporate Office...
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $13,283.20 to AmerisourceBergen Drug Corp for Act-O-Vials on October 31, 2025, with an ultimate completion date of November 3, 2025. This firm fixed price contract is non-competitive and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a $40,939.86 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Act-O-Vials medical products. This firm fixed-price delivery order, issued without a set-aside designation, is performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. The award represents a routine pharmaceutical supply transaction under the company's existing contract vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for Act-o-Vials on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,100.66 to AmerisourceBergen Drug Corp for Act-O-Vials on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. Performance will occur at the contractor's Corporate Office location...
- The Defense Logistics Agency awarded a delivery order valued at $6,860.20 to AmerisourceBergen Drug Corp for Act-O-Vials pharmaceutical products on September 17, 2025, with completion expected by September 18, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The prime contractor, headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a $13,421.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, with an ultimate completion date of the same day. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FARJPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,187.44 to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Act-O-Vials pharmaceutical products. This firm fixed price delivery order, with a completion date of November 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. As the prime contractor on the $999.99 billion DLA Troop Support Medical IDC (designated SPE2DX and running through December 2026), the company supplies an extensive portfolio of pharmaceutical products and medical commodities globally, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems through flexible contract vehicles designed to meet ongoing military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/5/25 |